Initial high antimemetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles
1998

Efficacy of Granisetron and Dexamethasone in Preventing Nausea During Chemotherapy

Sample size: 125 publication Evidence: moderate

Author Information

Author(s): R de Wit, H van den Berg, J Burghouts, J Nortier, P Slee, C Rodenburg, J Keizer, M Fonteyn, J Verweij, J Wils

Primary Institution: Rotterdam Cancer Institute and University Hospital

Hypothesis

Does the combination of granisetron and dexamethasone maintain its anti-emetic efficacy over multiple cycles of cisplatin chemotherapy?

Conclusion

The anti-emetic efficacy of granisetron combined with dexamethasone decreases over multiple cycles of chemotherapy.

Supporting Evidence

  • The initial complete protection rate against acute emesis was 66%, which decreased to 30% by the sixth cycle.
  • The initial complete protection rate against delayed emesis was 52%, which decreased to 21% by the sixth cycle.
  • Protection failure in the delayed emesis phase adversely influenced acute emesis protection in subsequent cycles.

Takeaway

This study found that the medicine used to prevent nausea during chemotherapy works less well after several treatments.

Methodology

Patients received cisplatin and were treated with granisetron and dexamethasone, with efficacy assessed over multiple cycles.

Potential Biases

Potential bias due to protocol violations and withdrawals.

Limitations

The study had a high withdrawal rate, and the results may not apply to all chemotherapy regimens.

Participant Demographics

125 patients, 43 male and 82 female, mean age 56 years.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI 57-75% for acute emesis, 95% CI 42-62% for delayed emesis

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication